# The economic crisis and drug shortages, as reported by cancer patients in Beirut

Source: https://onco.cc/key-papers/paper-eid-drug-shortage-lebanon-wjco-2024/  
OnCo record `paper-eid-drug-shortage-lebanon-wjco-2024` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

In February 2022, about a third of outpatients receiving cancer treatment at a Beirut hospital had had their treatment interrupted, mainly by drug shortages, and most had paid for medicines themselves despite having insurance.

## Summary

Published as "Impact of the economic crisis and drug shortage on Lebanese cancer patients' care". A questionnaire given in February 2022 to patients in the outpatient oncology department of Hôtel-Dieu de France University Hospital, Beirut.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: World Journal of Clinical Oncology
- Year: 2024
- DOI: 10.5306/wjco.v15.i5.644
- Authors: Eid D, Jabbour J, Moujaes E, et al.
- Findings: Among 182 patients, 31.87% experienced treatment interruption, mainly because of acute drug shortages.; Although 87.91% had third-party coverage, 69.60% had to pay for their medications themselves.; One third showed symptoms of anxiety or depression; 89.66% of those who altered their treatment cited financial difficulties.
- What it means: Describes, from patients, what the medicine shortage of 2021 and 2022 meant: interrupted treatment and insurance that no longer paid.
- Caveats: One hospital, one month.; Self-reported.

## Sources

- World J Clin Oncol 2024: https://doi.org/10.5306/wjco.v15.i5.644
- PubMed: https://pubmed.ncbi.nlm.nih.gov/38835845/

## Connected records

- institutions: [Ministry of Public Health, Lebanon](https://onco.cc/institutions/lebanon-ministry-of-public-health/)

---
JSON: https://onco.cc/api/v1/entities/paper-eid-drug-shortage-lebanon-wjco-2024.json